activeDCM - Interventional Clinical Trial of Individualized Activity and Exercise Programs to Improve Outcome in Dilated Cardiomyopathy Guided by Longitudinal Biosensing With Apple Watch (ACTIVE-DCM)
Cardiomyopathy, Dilated, Heart Failure
About this trial
This is an interventional treatment trial for Cardiomyopathy, Dilated focused on measuring Exercise, SmartWatch, Wearables, Digital Health, Dilated Cardiomyopathy
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of non-ischemic, dilated cardiomyopathy (DCM)
- EF ≤ 45%
- NYHA I-III
- Age 18 to 65 years
- The patient understood the study concept and the declaration of consent and signed and dated the declaration of consent
Exclusion Criteria:
- Physical disability that is not compatible with exercise in the study
- Orthopedic diseases such as osteoarthritis or changes in the spine that lead to restrictions that are not compatible with exercise in the study
- Syncope within the past 3 months
- Pregnancy
Sites / Locations
- Department III of Internal Medicine, University Hospital HeidelbergRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
No Intervention
Intervention group with motivation messages
Intervention group without motivation messages
Control group
There are 100 patients in the intervention group with automated or observer initiated motivation messages. They receive an individualized training program with regular notifications about their training status via their SmartWatch.
There are 100 patients in the intervention group without automated or observer initiated motivation messages. They receive an individualized training program without regular notifications about their training status via their SmartWatch.
100 patients are in the control group without an individualized training program.